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Abstract .
Two new mAbs (M/K-1 and M/K-2) define
an
adhesion molecule expressed on stromal cell clones
derived
from murine bone marrow
.
The protein is sim-
ilar
in size to a human endothelial cell adhesion mole-
cule
known as VCAM-1 or INCAM110
.
VCAM-1 is
expressed
on endothelial cells in inflammatory sites
and
recognized by the integrin VLA-4 expressed on
lymphocytes
and monocytes
.
The new stromal cell
molecule
is a candidate ligand for the VLA-4 expressed
on
immature B lineage lymphocytes and a possible ho-
mologue
of human VCAM-1
.
We now report additional
similarities
in the distribution, structure, and function
of
these proteins
.
The M/K antibodies detected large
cells
in normal bone marrow, as well as rare cells in
other
tissues
.
The antigen was constitutively expressed
and
functioned as a cell adhesion molecule on cultured
L
a term bone marrow culture techniques make it pos-
sible
to define molecular and cellular interactions
which
may regulate production of blood cells in vivo
(28) .
These experimental approaches are particularly well
developed
for studies of mice, where bone marrow cultures
can
be used to selectively sustain growth of immature my-
eloid
or lymphoid cells
.
Furthermore, cloned stromal cell
lines
are available to which cloned lymphoid cells attach and
are
stimulated to divide
.
Stromal cells are a source ofmany
cytokines
and it has been suggested that the production of
one
pre-B growth factor results from direct contact ofimma-
ture
lymphocytes with them (29, 61)
.
Thus, cell adhesion
molecules
(CAMS)' on stromal cells could be important for
signal
transmission, as well as for mediating lymphocyte
binding .
Many
CAMs have been identified on erythroid, myeloid,
and
lymphoid progenitors, as well as on stromal elements
with
which they interact (5, 7, 19, 30, 32, 43, 50, 62)
.
The
1 .
Abbreviations used in thispaper
:
CAM, cell adhesion molecule
;
EOMA,
hemangioendothelioma ;
PI-PLC, phospholipase C
.
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murine
endothelial cells
.
It correlated with the pres-
ence
of mRNA which hybridized to a human VCAM-1
cDNA
probe
.
Partial NHZ terminal amino acid sequenc-
ing
of the murine protein revealed similarities to
VCAM-1
and attachment of human lymphoma cells to
murine
endothelial cell lines was inhibited by the M/K
antibodies .
All of these observations suggest that the
murine
and human cell adhesion proteins may be re-
lated .
The antibodies selectively interfered with B lym-
phocyte
formation when included in long term bone
marrow
cultures
.
Moreover, they caused rapid detach-
ment
of lymphocytes from the adherent layer when
added
to preestablished cultures
.
The VCAM-like cell
adhesion
molecule on stromal cells and VLA-4 on lym-
phocyte
precursors may both be important for B lym-
phocyte
formation
.
murine
equivalent ofCD44 was the first one to be directly
implicated
in lymphocyte formation (35)
.
mAbs to CD44
completely
blocked formation of myeloid or lymphoid cells
when
continuously added to long term bone marrow cul-
tures .
However, CD44 does not seem to be important for
binding
ofpre-B cells to stromal cells andmAbs were devel-
oped
that define another pair of adhesion molecules (37)
.
B
lineage
lymphocytes and their precursors express the inte-
grin
VLA-4 and antibodies (PS/2) to this molecule preferen-
tially
inhibited lymphopoiesis in culture
.
Two
antibodies (M/K-1 and M/K-2) prepared to stromal
cells
detect another cell adhesion molecule and it is similar
in
size to one of two known ligands for VLA-4
.
Transfection
and
other studies inhumans revealed that VLA-4 recognizes
a
single-chain glycoprotein known as VCAM-1 or INCAM
110,
whose expression on endothelial cells is dramatically
induced
by inflammatory agents (12, 16, 21, 47)
.
It seemed
possible
that our M/K antibodies recognize a murine homo-
logue
ofVCAM-1 and that this molecule functions in bone
marrow
as a ligand for the VLA-4 on pre-B cells
.
We now
provide
additional information about the tissue distribution,
structure
and function of this cell adhesion molecule
.
557Materials andMethods
CellLinesandmAbs
The murine hemangioendothelioma (EOMA) and aorta endothelial cell
lines havebeen described (4, 40). They were verified on the basis ofexpres-
sion of acetylated LDL receptors and angiotensin converting enzyme. The
+/+ 2.4 stromal cell clone was a gift of Dr. Joel S. Greenberger at the
University of Massachusetts (Boston, MA) (3). All other cell lines were ei-
therobtained from the American Type Culture Collection (Rockville, MD)
or derived in our laboratory and described in previous publications (37) .
Similarly, the derivation of mAbs has been described (35, 37). As in our
previous studies, antibodies were purified from ascites fluid prepared in im-
munodeficient C.B-17 scid/scid mice.
Northern Blots
Total RNA was extracted and analyzed on Northern blots exactly as in our
previous studies (17) . The stringency ofwash conditions were twice at room
temperature (10 min each) and once for 30 min at 50°C in 2x SSC with
0.1% SDS. This was followed by two additional washes of 15 min each at
50°C in 0.lx SSC with 0.1% SDS.
Immunoprecipitation andProtein Sequencing
Up to 100 culture dishes (100 mm) of +/+ 2.4 stromal cells were harvested
with a silicone policeman, pooled, and extracted with 1% Triton X-100, 50
mM Tris/HCI, pH 7.5, 150 mM NaCl, 50 mM iodoacetamide, 2 mM
MgC12, 2 mM CaC12, 0.1% NaN3, 10 ug/ml trypsin inhibitor, 1 Am/ml
leupeptin, 1 U/ml aprotinin, and 1 mM PMSF. After centrifugation, the ly-
sate was precleared twice with goat serum-coupled Affigel 10 (Biorad
Laboratories, Cambridge, MA) beads and once with goat anti-rat Ig cou-
pled Sepharose beads loaded with rat IgG. Specific complexes were then
collected on goatanti-rat Ig Sepharose beads loaded with M/K-1.2 antibod-
ies by incubation at 4°C overnight. These beads were then washed twice
with 0.2% Triton X-100, 0.6 M NaCl, 50 mM Tris/HCI, pH 7.5, 0.1%
NaN3. Protein was eluted from the beads by boiling for 5 min in Laemmli-
reducing SDS solution and subjected to PAGE on 7.5% gels. The protein
was then electrophoretically transferred to polyvinyl difluoride membranes
(Millipore Continental Water Systems, Bedford, MA) and visualized by
Coomassie blue staining. N112-terminal amino acid sequence analyses were
performed on a gas-phase protein sequencer equipped with an on-line phenyl-
spleen
￿
bone marrow
Fluorescence Intensity
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thiohydantoin amino acid analyzer (Applied Biosystems, Foster City, CA).
These determinations were made by Dr. Ken Jackson in the Molecular Biol-
ogy Resource Facility of the Saint Francis Hospital of Tulsa Medical Re-
search Institute (Oklahoma City, OK). Each residue was detected 2-4 times
in four completely independent experiments.
Immunofluorescence andImmunoperoxidase Staining
Cells in suspension were preincubated for 20 min on ice with mAbs that
had been biotinylated or were unlabeled. After two washes, either fluores-
cein-labeled streptavidin (Zymed Laboratories, S. San Francisco, CA) or
mouse anti-rat Ig was added for an additional incubation. Propidium iodide
was added during this time and used as a gating parameter to exclude non-
viable cells. Labeled cells were then evaluated by flow cytometry on either
a Coulter EPICS or FACScan (Becton Dickinson & Co., Mountain View,
CA) . In some experiments, normal spleen, 70Z/3, or endothelioma cells
were pretreated with phosphatidylinositol-specific phospholipase C (PI-
PLC) from Bacillus thuringiensis. This highly purified enzyme was a gift
from Dr. Martin Low (Columbia University, New York) and was used as
in our previous study (33). As positive controls, we monitored the release
of Thy-1 and/or Ly-6 antigens. Tissues were removed for histology and snap
frozen in O.C.T. embedding medium (Miles Laboratories Inc., Elkhart, IN)
using a 2-methylbutane bath submerged in liquid N2. Sections of 4-6 Wm
were fixed in acetone for 2 min at -20°C, washed in PBS, and treated with
NaN3 and H202 before blocking with BSA. They were then stained and
processed with a kit from Zymed Laboratories. Bone marrow plugs were
expelled with medium and processed the same way.
CellAdhesionAssay
Cell lines were radiolabeled by incubation of 50 x 106 cells/ml in saline
with 20% FCS and Na251CrO4 for 2 h at 37°C. They were then washed
three times before addition of 105 cells to adherent cell layers. The latter
were plated in 24 well plates at 3 x 104 cells/well and allowed to grow for
two days before use in adhesion assays. After 30 min ofcoculture at 37°C,
unbound cells were removed by three cycles ofwashing in prewarmed com-
plete medium. Before each aspiration, plates were vigorously agitated on
a Vortex mixer to which a plate adaptor was attached. Bound cells were
lysed with 0.1 N NaOH, 0.1% Triton-X100 and the "Cr counted with a
gamma counter (Hewlett Packard Co., Palo Alto, CA). Percentages of
bound cells were determined by the formula: percent bound = Qcpm from
bound cells]/[input cell associated cpm - spontaneously released cpm]) x
thymus
￿
lymph node
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Figure 1. Differential patterns of expression of the integrin VLA-4 (detected by monoclonal PS/2 antibody) and a stromal cell adhesion
molecule (M/K-1 antibody) on murine cell suspensions. Immunofluorescent staining and flow cytometry were performed as detailed in
the Materials and Methods. Solid lines depict specific staining and negative control histograms are shown with dotted lines.100 . Antibodies (10 pm/ml) were added at the same time as the "Cr-la-
beled lymphoma cells .
Long Term Cultures andAntibody Treatments
Long term bone marrow cultures were initiated and maintained exactly as
in our previous studies (35, 37) . These techniques were based on those de-
veloped by Whitlock and Witte (66) . In some experiments, the indicated
amounts of mAbs were added at the initiation of culture and with each
feeding .
Detachment ofLymphocytesfrom StromalCells
Whitlock-Witte cultures were set up under standard conditions and main-
tained for at least 5 wk. At this time, numerous foci of lymphocytes were
present attached to the adherent layers . All nonadherent and easily mobi-
lized lymphocytes were removed by gentle agitation and aspiration . Then,
3 nil of medium containing either antibodies (5 Ag/ml) or PI-PLC (added
in 10-fold excess of that required for Thy-1 or Ly-6 release) was added to
the flasks . In most experiments, the cultures were incubated at 37°C for
2 h before removing this medium and performing hemacytometer counts .
Then 3ml of0.02% EDTA in PBS was added to each flaskand held 10 min
at room temperature to remove all remaininglymphocytes. These were also
counted and the sum collected in both treatments was used as the number
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Figure 2. Both VLA-4 and the stromal cell
antigen are constitutively expressed in mu-
rine bone marrow. Frozen sections ofnormal
marrow plugswere analyzed by immunoper-
oxidase staining with a monoclonal antibody
to VLA-4 (PS/2) or the stromal cell antigen
(M/K-1) . The background in control sections
treated with an isotype matched, irrelevant
mAb was extremely low (not shown) . Bar,
10 jum.
oftotal releasable lymphocytes . Inoneexperiment, which only involved ad-
dition of antibodies, the flasks were first prechilled to 4°C .
Results
7Fssue Distribution ofaStromalCAM
We previously prepared twomAbs (M/K-1 andM/K-2) which
recognize an ti100-kD adhesion molecule expressed on a
cloned stromal cell line (37) . Cross-blocking experiments
indicate that the antibodies detect very closely related, if not
identical epitopes (data not shown) . This stromal cell antigen
is a possible murine homologue ofhuman VCAM-1, which
is known to be a ligand for the integrin VLA-4 (12) .
Significant numbers of cells positive for the stromal cell
antigen were only present in bone marrow suspensions (Fig .
1) . This subpopulationhadforwardandrightangle light scat-
terproperties typicaloflarge cells (data not shown) .A retic-
ular pattern was observedwhen bone marrow was sectioned
and examined by immunoperoxidase staining (Fig . 2) . In
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contrast, VLA-4 was detected by the PS/2 antibody on a ma-
jority of lymphohemopoietic cells in marrow, as well as in
peripheral lymphoid tissues . A survey of other tissues re-
vealed the Peyer's patches to be another site where the
VCAM-like molecule was detected . In sections of lymph
nodes, skin, spleen, and thymus, only very weak staining of
widely scattered cells was obtained with theM/K antibodies .
This included a small fraction of the follicular dendritic cells
in germinal centers . Also, a subset of thymic macrophages
appeared to be positive . VCAM-1/INCAM110 is known to be
inducible onhuman endothelial cells (13, 45-47) . Similarly,
we found that the stromal cell antigen was constitutively ex-
pressed on two murine endothelial cell lines (Fig . 3) . There
have been no descriptions ofVCAM-1 in human bone mar-
row. Otherwise, the distribution of the murine stromal cell
antigen is generally consistent with that ofhuman VCAM-1 .
Northern blots were prepared with total RNA from a panel
of cell lines and probed with human VCAM-1 cDNA (42) .
A transcript of ti 3.2 kb, as well as a less abundant species
of -1.6 kb, was only detected in cell lines known to be posi-
tive for the stromal cell antigen by immunofluorescence anal-
ysis (Fig. 4) . Hybridization was also found with samples of
normal spleen . For comparison, the same blots were probed
withICAM-1 cDNA (58) . Therewas an entirely different pat-
tern of expression for this adhesion molecule and transcripts
were never detected in stromal cells (Fig . 4 and data not
shown) . These results demonstrate that a cell adhesion mole-
cule previously recognized on a murine stromal cell is con-
stitutively expressed in bone marrow and faintly represented
on reticular cells in other tissues . Like human VCAM-1, it
can be made by endothelial cells and is present in concor-
dance with mRNA which cross hybridizes with a human
VCAM-1 probe .
Structural Similarities to VCAM1
Treatment with PI-PLC substantially reduced the staining of
stromal cells or endothelial cells with antibodies to Ly-6, an
antigen known to be attachedto the membrane via a glycosyl
phosphatidylinositol linkage (46) . In contrast, this treatment
had no effect on the antigen detected by M/K antibodies or
on VLA-4 (see Materials and Methods) . Both of these may
be conventional transmembrane proteins .
Partial NH 2-terminal sequencing was then attempted with
immunoprecipitated protein and determinations were possi-
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Figure 3. Twomurinecelllines
of endothelial origin express
the stromal celladhesion mole-
cule. Viable suspensions ofthe
cultured cells were stainedand
analyzed by flow cytometry.
Histograms obtained with the
M/K-1 antibody are given as
solid lines and the irrelevant
controls (FD441.8 antibody to
LFA-1) are shown as dotted
lines .
ble for amino acids in positions 3 through 8 (Fig . 5) . Four
of these are identical to the published sequence of human
VCAM-1 (40) and one additional amino acid represents a
conservative substitution (serine to threonine) . Both amino
acid changes could result from single nucleotide substitu-
tions and no gaps or realignments were needed to reveal simi-
larities in the sequences . These observations are consistent
Figure 4 . Selective expression ofICAM-1 and VCAM-1 mRNNs in
murine tissues. TotalRNA was prepared from aorta endothelial and
endothelioma(EOMA) cell lines as well as early (e) and late (1) pas-
sages of the BMS2 stromal cell clone and used for Northern blot
analysis . Preparations were also made from B lymphoma (W231),
pre-B lymphoma (70Z/3), myelomonocytic leukemia (WEHI3),
and normal BALB/c spleen cells . A photograph of the ethidium
stained ribosomal RNA is also shown to demonstrate sample
loading .Figure S. Partial NHZ-termi-
nal amino acid sequence iden-
tity of human VCAM-1 and a
murine stromal cell adhesion molecule. The published human se-
quence is shown beginning with the first residue after the signal
peptide. Each murine amino acid was unambiguously detected at
least twice in four determinations. The serine to threonine differ-
ence is indicated as a conservative change.
Human: F K
Mouse:
with the possibility that the M/K antibodies recognize a mol-
ecule related to VCAM-1 .
Conservation ofVCAMIVLA-4-mediated
CellAdhesion
A previous study demonstrated that murine melanoma cells
bound to cytokine-activated human endothelial cells. This
adhesion was blocked by an antibody to human VCAM-
1/INCAM110 (47). The VLA-4 on murine melanoma cells
might therefore be able to recognize human VCAM-1 . We
have now found that the reciprocal relationship is also possi-
ble (Fig. 6) . TWo humancell lines, Ramos and Nalm 6, read-
ily attached to a murine endothelioma line and this recogni-
tion was significantly blocked by M/K and PS/2 antibodies.
An antibody to murine CD44 (KM201) had no effect. Al-
though PS/2 was developed and characterized as an antibody
to murine VLA-4, it also has some affinity for human cells
(37; and results not shown). It was consistently less effective
than the M/K antibodies in blocking adhesion of human
cells. Interaction of the human Ramos lymphoma to an en-
dothelial line derived from murine aorta was similar to the
results shown here, while binding of Nalm-6 to the same
line was more avid, and less efficiently inhibited (data not
shown) . Nalm-6 also quickly migrated beneath adherent
layers and this pseudo-emperipolesis was not inhibited by
any antibodies tested. Therefore, human cell lines can recog-
nize conserved adhesion ligands on murine endothelial cells.
In the examples shown, the binding must have been largely
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Figure 6. Adhesion of murine and human cell lines to a murine en-
dothelioma is at least partially mediated by the VCAM-like stromal
cell adhesion molecule. Murine B lymphoma (Wehi231), human
pre-B leukemia (Nalm6), and human Burkitt lymphoma (Ramos)
lines were "Cr labeled and used in the cell adhesion assay as de-
scribed in the Materials and Methods. mAbs (10 jg/ml) to murine
CD44 (KM201), VLA-4 (PS/2), and the VCAM-like antigen (MI
K-1) were addedas indicated. Note that the PS/2 antibody also has
a weak affinity for human cells.
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Table L Inhibition of Whitlock/Witte Cultures by Addition
ofMonoclonal M/KAntibodies
* Numbers offlasks with lymphocyte growth/total after 8 wk of culture. Long
term bone marrow cultures were initiated and maintained in the continuous
presence of mAbs at the indicated concentrations. Irrelevant control antibodies
include D7 (anti-Ly-6) and KMI-6, which detects an abundant antigen of
unknown function on stromal cells.
mediated by human VLA-4 and a murine VCAM-like mol-
ecule.
Participation ofthe VCAM-likeMolecule in Marrow
CellAdhesion
Evidence for the importance of CD44 and VLA-4 in lym-
pho-hemopoiesis was previously obtained by adding mAbs
to long term bone marrow cultures (35, 37) . Similar studies
were done with the M/K series antibodies (Table 1). In the
first experiment, lymphocyte production was not prevented
by including 3 ttg/ml of antibodies in the culture medium.
However, there was a striking effect on cell adhesion. A
small number of nonadherent lymphocytes are always pres-
ent in control cultures, but virtually all of the lymphocytes
were easily mobilized by gently tapping those flasks which
contained M/K antibodies. The only lymphocytes which re-
mained associated with the adherent layer were in small foci
beneath stromal cells (see Fig. 8). Lymphocytes that could
be recovered from M/K antibody containing cultures were
not unusual with respect to cell surface markers (results not
shown) . Another antibody, KMI6, detects a relatively abun-
dant protein expressed on bone marrow stromal cells, but
had no effect on cell adhesion assays or bone marrow cultures
(unpublished observations). It was used throughoutas a nega-
tive control. In subsequent experiments, where higher con-
centrations of M/K antibodies were usually added, lympho-
cyte production was totally inhibited in at least 75 % of the
culture flasks. The M/K antibodies had no effect on produc-
tion of myeloid cells when added to Dexter-type long term
bone marrow cultures (data not shown).
Preliminary experiments revealed that CD44 antibodies
only inhibited lymphopoiesis when added during the first
week of culture (data not shown). However, we found that
lymphocyte adhesion to stromal cells could be disrupted at
any stage by addition of the M/K or PS/2 antibodies (Fig.
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Group Antibody Concentration Positive/Total*
Control 3 wg/ml 5/5
KMI-6 3 rig/ml 5/5
I M/K-1 3 hg/ml 5/5
M/K-2 3 ttg/ml 5/5
Control 5 ug/ml 6/6
D7 5 Ag/ml 5/6
II M/K-1 5 jug/ml 1/6
M/K-2 5 wg/ml 2/6
Control 3 I+g/ml 4/4
KMI-6 3 jug/ml 4/4
III M/K-1 3 Wg/ml 1/4
M/K-2 3 ttg/ml 0/4
Control 5 ug/ml 4/4
KMI-6 5 Ag/ml 4/4
IV M/K-1 5 ug/ml 0/4
M/K-2 5 Ag/ml 0/4MOWN*
Discussion
10 20 30 40 50 60 70_
￿
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Figure 7. Lymphocytedetachment from established long term bone
marrow cultures by ml After removing any free-floating lym-
phocytes, medium was replaced with monoclonal antibodies (5
ug/ml) or PI-PLC. Numbers ofcells liberated from the stromal cell
layer during 2 h of subsequent incubation was determined as
detailed in the Materials and Methods. Monoclonal KMI-6 anti-
body detects an abundant antigen on stromal cells which has no
known function, KM201 recognizes murine CD44/Pgp-1, PS/2 de-
tects VLA-4, and M/K-2 is directed to a VCAM-like stromal cell
adhesion molecule. Data is shown from one of six similar experi-
ments.
7). In six experiments, an average of20.2 f 1.6 % ofthe lym-
phocytes spontaneously detached from the adherent layer
during one cycle of medium replacement and a 2-h incuba-
tion . Similarly, 17.5 t 3.5% of the cells were recovered
when an anti-CD44 antibody (KM201) was present. How-
ever, 'an average of 70.9 t 2 .1% of the lymphocytes were
liberated by antiVLA-4 (PS/2) and 88.6 f 1.4% were mobi-
lizedby the M/K (antiVCAM) antibodies. The effect of these
antibodies was readily apparent by microscopic examination
of the cultures (Fig. 8) . Focal adhesion of lymphocytes to
stromal cells was disrupted and only the slightest agitation
caused them to float into the medium. As in our previous
studies (67), essentially all of the surface adherent lympho-
cytes were detached by EDTA treatment, suggesting divalent
cations are important in the adhesion process. It is possible
that the antibodies only delivered a stimulus to lymphocytes
or stromal cells, such that lymphocytes are actively released.
However, similar results were obtained in one experiment,
where the entire procedure was performed at 4°C. Addition
of a highly purified PI-PLC from B. thuringiensis did not re-
sult in significant lymphocyte detachment (average 18.2 ±
2.5% release). Therefore, requirements for lymphocyte ad-
herence match the known properties of murine VLA-4 and
the VCAM-like molecule. The effects on long term bone
marrow cultures indicate that both CAMs may be critical to
interactions between lymphocytes and stromal cells.
These findings reveal structural and other similarities be-
tween a CAM expressed by murine stromal cells and one
known as VCAM-1 or INCAM110 in humans. The latter is
thought to function as a ligand for the integrin VLA-4 and
to mediate important functions in inflamed peripheral tis-
sues (12, 41, 42, 53). We now show that the murine VCAM-
like antigen is constitutively expressed in bone marrow,
where it appears to be recognized by VLA-4+ lymphocytes.
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Thus, the same pair of molecules which participate in
immune related responses may be critical to normal lym-
phopoiesis.
VCAM-1/INCAM 110 was first identified as an inducible
CAM on humanendothelial cellswhich couldmediate mela-
noma cell or lymphocyte binding (47, 48) . Lymphocytes,
monocytes, and natural killer cells may all recognize this
molecule on stimulated endothelial cells or follicular den-
dritic cellsof germinal centers (1, 8, 14, 20). The distribution
of VCAM-1 in human bone marrow has not been described
(59). However, information is accumulating aboutits expres-
sion in other human tissues, where it is particularly conspic-
uous in sites of inflammation (6, 49) . Particular cytokines
induce VCAM-1 on freshly isolated endothelial cells from
humans and primates (34, 63) . In this respect, endothelial
cells from different organs appear to respond to different
combinations of stimuli, suggesting there may be tissue
specific regulation of expression.
The M/K series of antibodies was prepared by immuniza-
tion with stromal cell clones derived from murine bone mar-
row (37) . We have now demonstrated that antigen positive
cells are present in normal bone marrow and that the antigen
can be expressed on endothelial cells. Two established en-
dothelial cell lines constitutively expressed this molecule,
where it was a functional CAM. Furthermore, the M/K anti-
bodies specifically recognize the endothelium of inflamed
murine cardiac allografts (Pelletier, Sedmak, Miyake, Kin-
cade, Ferguson and Orosz, manuscript submitted for publi-
cation) . Interestingly, antibodies to VCAM-1/INCAM110
have recently been used to monitor inflammation in human
cardiac transplants (6) .
As another indication of concordance, cell lines which ex-
pressed the stromal cell antigen also contained mRNAwhich
hybridized to a human VCAM-1 probe. Two types of tran-
scripts have thus far been isolated from human cells, which
differ only with respect to a 256 nucleotide insertion (23, 42,
45) . Using a humancDNA probe, we detected hybridization
to an -1.6-kb RNA species in murine cell lines, in addition
to the expected 3.2-kb transcript.
Similarities in NHZ terminal amino acid sequence be-
tween human VCAM-1 and the murine stromal CAM would
be consistent with a structural relationship between these
proteins and we also obtained evidence for common func-
tions. Certain human lymphoma lines have been previously
shown to selectively utilize VLA-4 for endothelial cell rec-
ognition (12, 14). Antibody blocking experiments indicate
that the attachmentofRamosand Nalm 6 cells to murine en-
dothelioma cells must have been largely dependent on hu-
man VLA-4 and murine VCAM-1 (Fig. 6). Murine F16 mela-
noma cells adhere to activated human endothelial cells via
VCAM-1 (47). Therefore, recognition between this pair of
CAMS may work across species in either direction.
Immunoperoxidase staining revealed some expression of
the VCAM-like antigen in sections ofmurine Peyer's patches
and thymus. VLA-4 and the closely related LPAM-1 mole-
cule are thought to direct lymphocyte traffic to murine
Peyer's patches (24, 25) and it will be interesting to learn if
a VCAM-like molecule functions as an adhesive ligand in
that circumstance. Polyclonal antibodies prepared against
thymic stromal cell clones by Kina and colleagues (27)
recognize a similar CAM(s) to that detected by our M/K an-
562tibodies, raising the possibility that B and T lymphopoiesis
havecommon features . However, additional adhesion mole-
cules have been described in the thymus (10, 22, 57) .
It is interesting to contrast the roles of CD44 and its
ligands with the molecules addressed in this study. Produc-
tion of myeloid and lymphoid cells were completely blocked
by inclusion of anti-CD44 antibodies in the medium (35) .
However, this was only the case if the antibodies were pres-
ent during the first week of culture and there was no effect
on adhesion or other functions in established cultures .
Ligands known to be recognized by CD44 include hyaluro-
nate, mucosal vascular addressin, and collagens (9, 15, 31,
36, 44) . One study indicated that collagens contribute to
stromal cell layer functions (68) and anti-CD44 might inter-
fere with some type of collagen recognition which is critical
at the outset of culture.
Antibodies to VLA-4 and theVCAM-like molecule prefer-
entially inhibited lymphopoiesis in culture (37), consistent
with the notion that other specialized CAMs may be impor-
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Figure8 . Effect ofmAbs to the VCAM-like
cell adhesion molecule on established bone
marrow cultures. Control cultures received
isotype matched irrelevant antibodies (A) .
With the exception of foci of lymphocytes
located beneath the adherent layer (arrow),
typical nests of lymphocytes on stromal
cells are disrupted within 2 h ofaddition of
M/K antibodies (B) . Bar, 50 jm .
tant for myeloid cell formation (7) . In every experiment,
lymphocyte outgrowth was completely prevented by anti-
VLA-4 addition (37) . In contrast, while lymphocyte detach-
ment always occurred in cultures containing the M/K series
antibodies, a fraction ofthe flasks continued to support lym-
phocyte growth (Table I) . An apparent greater efficiency of
inhibition by antiVLA-4 might suggest that stromal cells ex-
press functional ligands for VLA-4 other than the VCAM-
like molecule . It has been demonstrated that in addition to
VCAM-1, VLA-4 recognizes the CS-1 peptide sequence of
fibronectin (12, 16, 21) . Fibronectin receptors have been
described on lymphoma lines and B cell precursors, but
their function in lymphopoiesis has not been investigated (5,
30, 52) .
The fact that lymphocytes grew in a fraction ofcultures in
the presence of M/K antibodies suggests that their survival
does not require rigid contact . However, gravity should
bring them in close association with the stroma during incu-
bation . Also, the antibodies could deliver a signal to stromal
563cells similar to that normally achieved by lymphocyte adhe-
sion . Forexample, contact between lymphocytes and stromal
cells may stimulate production of IL-7, a pre-B cell growth
factor (61). In this context, it will be interesting to learn if
any ofthe CAMS play a signal transmitting role in bone mar-
row. Evidence is accumulating that VLA-4 and CD44 may
function as receptors and/or accessory molecules on mature
lymphocytes and monocytes (11, 26, 38, 54, 55, 65).
Disruption ofbinding of immature lymphocytes to stromal
cells was virtually complete within 2 h of addition of anti-
bodies to VLA-4 or the VCAM-like antigen (Figs. 7 and 8).
While these observations indicate that VLA-4 and a VCAM-
like molecule may be particularly important for B lym-
phopoiesis, CAMS frequently function in concert (51, 60) .
Further study is required to establish their importance in
vivo and to determine if other molecules are involved. An-
other exciting area of investigation will be the modulation
of functional adhesion during pre-B cell maturation. The
timely and selective release of mature lymphocytes into the
circulation and derangement of this in leukemia could in-
volve such CAMS. Since mature lymphocytes can recognize
VCAM-like molecules via VLA-4, the focus might be placed
on expression or function of the stromal cell CAMS. How-
ever, there is evidence for nonfunctional VLA-4 on various
cell types and the avidity of VLA-4 for fibronectin is immedi-
ately increased on T cells with activation (18, 24, 56, 64) .
Indeed, we have observed that some transformed VLA-4
positive pre-B cell lines do not recognize the VCAM-like
adhesion ligand (unpublished observations). Conforma-
tional changes probably occur in the extracellular domains
of other integrins in concert with changes in their affinities
for ligand (2, 13, 39). Down regulation ofVCAM expression
or a reduction in the density and/or function of VLA-4 at an
appropriate stage would permit detachment of mature lym-
phocytes from stromal cells.
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